获得性血友病A的自身抗体靶点不限于因子VIII:来自GTH-AH 01/2010研究的数据
该病例对照研究纳入获得性血友病A患者及年龄匹配对照,检测抗核抗体、抗胞质抗体及可提取核抗原自身抗体。患者抗核抗体阳性率64% vs 对照30%(OR 4.02,1.98-8.18),针对因子VIII以外任一靶点的自身抗体阳性率78% vs 46%(OR 4.16,1.98-8.39),提示获得性血友病A可能涉及更广泛的免疫耐受破坏。
要点
- 获得性血友病A患者抗核抗体阳性率64% vs 对照30%(OR 4.02,1.98-8.18)。
- 针对因子VIII以外任一靶点的自身抗体阳性率78% vs 对照46%(OR 4.16,1.98-8.39)。
- 7种特征明确的单克隆抗因子VIII抗体未使HEp-2细胞染色,排除交叉反应。
核心结论
- 获得性血友病A与多种自身抗体模式相关,提示其病理可能涉及更广泛的免疫耐受破坏。
研究设计与样本
- 病例对照研究,纳入获得性血友病A患者及年龄匹配对照。
- 采用HEp-2细胞免疫荧光筛查抗核抗体和抗胞质自身抗体。
- 采用酶免疫分析检测针对SS-A/Ro、SS-B/La、U1RNP、Scl-70、Jo-1、着丝粒蛋白B、Sm、双链DNA和α-胞衬蛋白的可提取核抗原自身抗体。
主要发现
- 获得性血友病A患者抗核抗体阳性率64% vs 对照30%(OR 4.02,1.98-8.18),且患者抗核抗体滴度高于对照。
- 获得性血友病A患者抗胞质自身抗体和抗α-胞衬蛋白免疫球蛋白A自身抗体较对照更常见。
- 针对因子VIII以外任一靶点的自身抗体在获得性血友病A患者中占78% vs 对照46%(OR 4.16,1.98-8.39)。
- 排除基线自身免疫病、肿瘤、妊娠或免疫抑制治疗受试者后的敏感性分析及多变量二元逻辑回归结果相似。
- 7种特征明确的单克隆抗因子VIII抗体混合物未使用于抗核抗体检测的HEp-2细胞染色。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The root cause of autoantibody formation against factor VIII (FVIII) in acquired hemophilia A (AHA) remains unclear. We aimed to assess whether AHA is exclusively associated with autoantibodies toward FVIII or whether patients also produce increased levels of autoantibodies against other targets. A case-control study was performed enrolling patients with AHA and age-matched controls. Human epithelial cell (HEp-2) immunofluorescence was applied to screen for antinuclear (ANA) and anticytoplasmic autoantibodies. Screening for autoantibodies against extractable nuclear antigens was performed by enzyme immunoassay detecting SS-A/Ro, SS-B/La, U1RNP, Scl-70, Jo-1, centromere B, Sm, double-stranded DNA, and α-fodrin (AF). Patients with AHA were more often positive for ANA than control patients (64% vs 30%; odds ratio [OR] 4.02, 1.98-8.18) and had higher ANA titers detected than controls. Cytoplasmic autoantibodies and anti-AF immunoglobulin A autoantibodies were also more frequent in patients with AHA compared with controls. Autoantibodies against any target other than FVIII were found in 78% of patients with AHA compared with 46% of controls (OR 4.16, 1.98-8.39). Results were similar preforming sensitivity analyses (excluding either subjects with autoimmune disorders, cancer, pregnancy, or immunosuppressive medication at baseline) and in multivariable binary logistic regression. To exclude that autoantibody staining was merely a result of cross-reactivity of anti-FVIII autoantibodies, we tested a mix of 7 well-characterized monoclonal anti-FVIII antibodies. These antibodies did not stain HEp-2 cells used for ANA detection. In conclusion, a diverse pattern of autoantibodies is associated with AHA, suggesting that a more general breakdown of immune tolerance might be involved in its pathology.
引用
- Oleshko O, Werwitzke S, Klingberg A, et al. Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study. Blood Adv. 2023. PMID: 35947142. doi:10.1182/bloodadvances.2022008071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。